We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$643M
AUM Growth
+$15.8M
Cap. Flow
+$13.3M
Cap. Flow %
2.06%
Top 10 Hldgs %
33.51%
Holding
182
New
13
Increased
48
Reduced
82
Closed
5

Top Buys

Rank Stock Value
1
EQNR icon
Equinor
EQNR
+$3.96M
2
D icon
Dominion Energy
D
+$2.87M
3
AMT icon
American Tower
AMT
+$2.78M
4
AMZN icon
Amazon
AMZN
+$2.42M
5
LITE icon
Lumentum
LITE
+$2.3M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$12M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.07M
3
SLB icon
SLB Ltd
SLB
+$1.14M
4
EMR icon
Emerson Electric
EMR
+$987K
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$788K

Sector Composition

Rank Sector Weight
1 Technology 26.66%
2 Healthcare 19.97%
3 Industrials 16.39%
4 Utilities 13.71%
5 Energy 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$32.8M 5.1%
375,953
-11,297
-3% -$987K
GLW icon
2
Corning
GLW
$128B
$26.7M 4.16%
757,433
-17,709
-2% -$616K
BMY icon
3
Bristol-Myers Squibb
BMY
$136B
$25.5M 3.96%
367,497
-9,128
-2% -$644K
PFE icon
4
Pfizer
PFE
$159B
$24.2M 3.76%
592,521
-14,969
-2% -$647K
OGE icon
5
OGE Energy
OGE
$9.45B
$22.2M 3.45%
589,832
-8,930
-1% -$336K
CSCO icon
6
Cisco
CSCO
$433B
$20.1M 3.13%
384,565
-6,657
-2% -$325K
NVS icon
7
Novartis
NVS
$292B
$17.3M 2.69%
188,045
-6,166
-3% -$539K
IBM icon
8
IBM
IBM
$222B
$17.3M 2.68%
131,637
+742
+0.6% +$99.3K
TEL icon
9
TE Connectivity
TEL
$58.7B
$15M 2.33%
114,234
-1,900
-2% -$240K
SLB icon
10
SLB Ltd
SLB
$85.1B
$14.5M 2.26%
295,437
-21,442
-7% -$1.14M
TSM icon
11
TSMC
TSM
$2.17T
$13.1M 2.04%
140,902
-1,118
-0.8% -$100K
MDU icon
12
MDU Resources
MDU
$4.16B
$12.5M 1.94%
1,076,152
-7,521
-0.7% -$87.4K
XOM icon
13
ExxonMobil
XOM
$644B
$12.5M 1.94%
113,598
-108,246
-49% -$12M
BCE icon
14
BCE
BCE
$21.9B
$11M 1.71%
245,420
+14,688
+6% +$664K
INTC icon
15
Intel
INTC
$473B
$10.9M 1.69%
333,450
+37,310
+13% +$1.06M
MRK icon
16
Merck
MRK
$366B
$10.8M 1.68%
101,691
-663
-0.6% -$71.6K
MSFT icon
17
Microsoft
MSFT
$3.81T
$10.3M 1.61%
35,884
-929
-3% -$237K
LNN icon
18
Lindsay Corp
LNN
$1.16B
$9.32M 1.45%
61,700
-1,100
-2% -$166K
HZNP
19
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$8.95M 1.39%
81,987
-1,375
-2% -$152K
TMO icon
20
Thermo Fisher Scientific
TMO
$230B
$8.73M 1.36%
15,144
-175
-1% -$98.6K
DIS icon
21
Walt Disney
DIS
$187B
$8.22M 1.28%
82,116
+21,900
+36% +$2.21M
BKH icon
22
Black Hills Corp
BKH
$5.55B
$8.05M 1.25%
127,530
-3,000
-2% -$198K
TMP icon
23
Tompkins Financial
TMP
$1.41B
$7.9M 1.23%
119,330
+5,800
+5% +$427K
AMZN icon
24
Amazon
AMZN
$2.87T
$7.76M 1.21%
75,090
+25,090
+50% +$2.42M
AMT icon
25
American Tower
AMT
$82.1B
$7.46M 1.16%
36,515
+13,266
+57% +$2.78M
1
2 3 4 5

Similar funds

SWIG
Strategic Wealth Investment Group Louisville, Kentucky $825M AUM 11.63% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $824M AUM 40.45% 1-Year Est. Return
WRPWM
Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $823M AUM 36.99% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $826M AUM 47.87% 1-Year Est. Return
MGAM
McGowan Group Asset Management Dallas, Texas $823M AUM 27.48% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $826M AUM 21.35% 1-Year Est. Return

John G. Ullman & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, John G. Ullman & Associates held 182 positions worth $643M, up 2.5% from $627M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

John G. Ullman & Associates's Q1 2023 filing shows 13 new, 48 increased, 82 reduced and 5 closed positions. Its largest new stake was United Therapeutics: 8,425 shares worth $1.89M. The largest sale was ExxonMobil, an estimated $12M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • John G. Ullman & Associates's largest Q1 2023 buy was United Therapeutics: 8,425 shares worth $1.89M.
  • John G. Ullman & Associates added most to Equinor in Q1 2023, an estimated $3.96M increase.
  • John G. Ullman & Associates's biggest Q1 2023 reduction was ExxonMobil, cutting an estimated $12M.
  • John G. Ullman & Associates fully exited Regeneron Pharmaceuticals in Q1 2023, selling an estimated $3.07M.
  • John G. Ullman & Associates's ten largest holdings make up 34% of its $643M portfolio in Q1 2023.
  • John G. Ullman & Associates opened 13 new positions and closed 5 in Q1 2023.
  • John G. Ullman & Associates's portfolio value rose 2.5% quarter-over-quarter to $643M.

Based on John G. Ullman & Associates's 13F filing for Q1 2023, filed 5 May 2023.